IRF9 and cancer: We confirmed the activation of IFN‐I signaling in cancer cells with MSC‐DC, as reflected by increased phosphorylation of STAT1 and STAT2[48] and increased IRF9 expression,[48] which was reduced by Gap26 (Figure 4C).